Submission for podium and poster presentations are due by July 29, 2016. Areas of particular interest for DDL27 include: • Inhalers – were they really meant for humans? • Beyond Asthma and COPD • 60 Years of the pMDI •Innovations in Aerosol Delivery • The Pat Burnell New Investigator Award. Submit abstracts at http://ddl-conference.com/?q=+PosterGuidelines_ddl27
DDL 27
published on
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
December 9-December 11: DDL 2026, Edinburgh, Scotland
April 27-30: RDD Europe 2027, Antibes, France
May 12-13: USP Joint Workshop: Quality and Product Performance Testing of Orally Inhaled and Nasal Drug Products, Rockville, MD, USA
June 30: RespireX 2027, Boston, MA, USA